Controlled dissolution of active ingredients

Details Controlled dissolution of active ingredients Controlled dissolution of active ingredients

2006-12-26

2006-12-26

Hartley, Michael G. (Department: 1618)

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Ion exchange resin

C424S078110, C424S078160, C424S486000

Reexamination Certificate

active

07153497

ABSTRACT:
A dosage form comprising a resin/resinate combination is described. Said dosage form allows optimization of the release rate profile of active ingredients.

REFERENCES:
patent: 4133696 (1979-01-01), Barker et al.
patent: 4510128 (1985-04-01), Khanna
patent: 4898729 (1990-02-01), Miller et al.
patent: 5811436 (1998-09-01), Leonard et al.
patent: 0391518 (1990-10-01), None
patent: WO 91/13612 (1991-09-01), None
patent: WO9211001 (1992-09-01), None
Advanced Analytical Biochemistry ion Exchange Chromatography; Principles and Applications of High Performance Ion-Exchange Chromatography for bioseparations from The separations Group, Hesperia, CA, USA (1998).
Basic principles in ion exchange chromatogrphy from the Amersha, biosciences group.
Pope et al., “Oral Controlled-Release Delivery of Ivermectin In Cattle via an Osmotic Pump”, Journal of Pharmaceutical Sciences, vol. 74, No. 10, pp. 1108-1110, 1985.
Theeuwes et al., “Elementary Osmotic Pump of Indomethacin”, Journal of Pharmaceutical Sciences, vol. 72, No. 3, pp. 253-258, 1983.
Conte et al., “Compressed Barrier Layers for Constant Drug Release from Swellable Matrix Tablets”, S.T.P. Pharma Sciences 4 (2) 107-113, 1994.
Kim et al., “Release Kinetics of Coated, Donut-Shaped Tablets for Water Soluble Drugs”, European Journal of Pharmaceutical Sciences, 9, 237-242, 1999.
Ganlin et al., “The Kinetics of Nimodipine Release from Swellable Hydrophilic Matrix”, Journal of Chinese Pharmaceutical Sciences, 9 (2), 104-107, 2000.
Sriwongjanya M et al; “Effect of ion exchange resins on the drug release from matrix tablets”; European Journal of Pharmaceutics and Biopharmaceutics, Elsevier Science Publishers B.V., Amsterdam, NL; vol. 46, No. 3; pp. 321-327.
Konar N et al; “Water-Soluble Polycations as Oral Drug Carriers (Tablets)”; Journal of Pharmaceutical Sciences, American Pharmaceutical Association. Washington, US'; vol. 86, No. 12; pp. 1339-1344.
Ichikawa Hideki et al; “Use of Ion-Exchange Resins to prepare 100 mum-sized microcapsules with prolonged drug-release by the Wurster process.”; International Journal of Pharmaceutics (Kidlington); vol. 216, No. 1-2, pp. 67-76; 2001.
Lele B S et al; “Mucoadhesive drug carriers based on complexes of poly (acrylic acid) and PEGylated drugs having hydrolysable PEG-anhyddride-drug linkages”; Journal of Controlled Release, Elsevier Science Publishers B.V. Amsterdam, NL: vol. 69, No. 2; pp. 237-248.

Affiliated with

Also associated with

Rating

Controlled dissolution of active ingredients does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled dissolution of active ingredients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled dissolution of active ingredients will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3660961